Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India.
MBBS, Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
J Gastroenterol Hepatol. 2024 Feb;39(2):256-263. doi: 10.1111/jgh.16385. Epub 2023 Nov 14.
Celiac disease (CeD) has now become a global disease with a worldwide prevalence of 0.67%. Despite being a common disease, CeD is often not diagnosed and there is a significant delay in its diagnosis. We reviewed the impact of the delay in the diagnosis on the severity of manifestations of CeD.
We reviewed clinical records of 726 consecutive patients with CeD from the Celiac Clinic database and the National Celiac Disease Consortium database. We extracted specific data including the demographics, symptoms at presentation, time of onset of symptoms, time to diagnosis from the onset of the symptoms, and relevant clinical data including fold-rise in anti-tissue transglutaminase antibody (IgA anti-tTG Ab) and severity of villous and crypt abnormalities as assessed using modified Marsh classification.
The median duration between the onset of symptoms and the diagnosis of CeD was 27 months (interquartile range 12-60 months). A longer delay in the diagnosis of CeD from the onset of symptoms was associated with lower height for age, lower hemoglobin, higher fold rise in IgA Anti tTG titers, and higher severity of villous and crypt abnormalities. About 18% of patients presented with predominantly non-gastrointestinal complaints and had a longer delay in the diagnosis of CeD.
There is a significant delay in the diagnosis of CeD since the onset of its symptoms. The severity of celiac disease increases with increasing delay in its diagnosis. There is a need to keep a low threshold for the diagnosis of CeD in appropriate clinical settings.
乳糜泻(CeD)现已成为一种全球性疾病,全球患病率为 0.67%。尽管这是一种常见疾病,但 CeD 常常未被诊断,且其诊断存在显著延迟。我们回顾了延迟诊断对 CeD 表现严重程度的影响。
我们回顾了乳糜泻诊所数据库和全国乳糜泻疾病联合会数据库中 726 例连续 CeD 患者的临床记录。我们提取了具体数据,包括人口统计学资料、发病时的症状、症状发作时间、从症状发作到诊断的时间,以及相关临床数据,包括抗组织转谷氨酰胺酶抗体(IgA 抗 tTG Ab)的倍数升高和使用改良 Marsh 分类评估的绒毛和隐窝异常的严重程度。
症状发作与 CeD 诊断之间的中位时间间隔为 27 个月(四分位距 12-60 个月)。CeD 从症状发作到诊断的延迟时间越长,身高年龄越低、血红蛋白越低、IgA 抗 tTG 滴度倍数升高越高、绒毛和隐窝异常的严重程度越高。约 18%的患者主要表现为非胃肠道症状,CeD 的诊断延迟时间更长。
CeD 从症状发作到诊断存在显著延迟。CeD 的严重程度随诊断延迟时间的增加而增加。在适当的临床环境中,需要保持对 CeD 诊断的低门槛。